American Century Companies Portfolio holdings
American Century Companies, Inc., founded in 1958 by James E. Stowers Jr. as Twentieth Century Mutual Funds and headquartered in Kansas City, Missouri, is a privately held investment management firm renowned for its focus on delivering investment results to clients while supporting medical research. Starting with just $100,000 from 24 shareholders, it rebranded to American Century Investments in 1997 and now manages hundreds of billions in assets across mutual funds, ETFs, and institutional portfolios, emphasizing no-load funds and a client-centric approach. The firm’s unique ownership structure sees over 40% of its profits funneled to the Stowers Institute for Medical Research, which it majority-owns, funding groundbreaking biomedical research, while Nomura Holdings holds a significant minority stake. With a global presence in cities like New York, London, and Hong Kong, and a workforce of around 1,400, American Century blends financial expertise with a mission to improve lives through both wealth creation and scientific advancement.
Top Buys
| 1 |
NVIDIA
NVDA
|
+$311M |
| 2 |
Humana
HUM
|
+$270M |
| 3 |
Meta Platforms (Facebook)
META
|
+$256M |
| 4 |
Colgate-Palmolive
CL
|
+$163M |
| 5 |
iShares Russell Mid-Cap Value ETF
IWS
|
+$160M |
Top Sells
| 1 |
Amazon
AMZN
|
+$653M |
| 2 |
Microsoft
MSFT
|
+$614M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$348M |
| 4 |
L3Harris
LHX
|
+$242M |
| 5 |
Idexx Laboratories
IDXX
|
+$238M |
Sector Composition
| 1 | Technology | 22.01% |
| 2 | Healthcare | 14.17% |
| 3 | Financials | 13.99% |
| 4 | Consumer Discretionary | 11.07% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TIGR
2451
UP Fintech Holding
TIGR
$1.96B
| $134K | ﹤0.01% |
40,978
+4,977
| +14% | +$16.2K |
|
2452
Allogene Therapeutics
ALLO
$251M
| $132K | ﹤0.01% |
26,492
+4,467
| +20% | +$22.2K |
|
2453
Noodles & Co
NDLS
$31.1M
| $131K | ﹤0.01% |
27,808
+2,177
| +8% | +$10.2K |
|
2454
Vanda Pharmaceuticals
VNDA
$262M
| $131K | ﹤0.01% |
19,466
-26,247
| -57% | -$176K |
|
2455
MacroGenics
MGNX
$98M
| $130K | ﹤0.01% |
18,265
+3,473
| +23% | +$24.7K |
|
|
FRBK
2456
DELISTED
Republic First Bancorp Inc
FRBK
| $129K | ﹤0.01% |
108,514
+30,720
| +39% | +$36.6K |
|
2457
Ginkgo Bioworks
DNA
$599M
| $128K | ﹤0.01% |
2,609
| – | – |
|
2458
Origin Materials
ORGN
$79.4M
| $128K | ﹤0.01% |
29,980
+7,020
| +31% | +$30K |
|
|
ROVR
2459
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $127K | ﹤0.01% |
28,380
+9,173
| +48% | +$41.1K |
|
|
PGRE
2460
Paramount Group
PGRE
$1.57B
| $127K | ﹤0.01% |
27,879
-79,688
| -74% | -$363K |
|
2461
BioCryst Pharmaceuticals
BCRX
$1.64B
| $125K | ﹤0.01% |
14,950
-192
| -1% | -$1.61K |
|
2462
Editas Medicine
EDIT
$236M
| $123K | ﹤0.01% |
17,530
+3,507
| +25% | +$24.7K |
|
|
AMTD
2463
AMTD IDEA Group
AMTD
$103M
| $123K | ﹤0.01% |
26,417
| – | – |
|
2464
XP
XP
$9.98B
| $122K | ﹤0.01% |
10,101
| – | – |
|
2465
Pitney Bowes
PBI
$1.96B
| $119K | ﹤0.01% |
31,614
+15,942
| +102% | +$60.1K |
|
2466
SiriusXM
SIRI
$7.88B
| $118K | ﹤0.01% |
2,989
-126,285
| -98% | -$5M |
|
2467
Quanterix
QTRX
$224M
| $118K | ﹤0.01% |
+10,877
| New | +$118K |
|
|
SHCR
2468
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
| $116K | ﹤0.01% |
79,279
+43,227
| +120% | +$63.1K |
|
2469
Magnachip Semiconductor
MX
$111M
| $113K | ﹤0.01% |
12,414
+2,332
| +23% | +$21.2K |
|
|
TSVT
2470
DELISTED
2seventy bio
TSVT
| $111K | ﹤0.01% |
+11,280
| New | +$111K |
|
2471
Janus International
JBI
$1.42B
| $110K | ﹤0.01% |
+11,300
| New | +$110K |
|
|
ABST
2472
DELISTED
Absolute Software Corporation Common Stock
ABST
| $110K | ﹤0.01% |
14,572
+213
| +1% | +$1.61K |
|
2473
First Bank
FRBA
$412M
| $110K | ﹤0.01% |
+11,024
| New | +$110K |
|
2474
CareDx
CDNA
$725M
| $109K | ﹤0.01% |
+12,339
| New | +$109K |
|
2475
Scholar Rock
SRRK
$3.22B
| $109K | ﹤0.01% |
14,222
+3,814
| +37% | +$29.2K |
|